DUBLIN, Oct. 6, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS:MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has appointed Susan Silbermann to its Board of Directors, effective October 5, 2022. With the addition of Ms. Silbermann, the Mallinckrodt Board will expand to nine directors, eight of whom are independent.
Read more at prnewswire.comMallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors
/Apple%20Inc%20logo%20on%20Apple%20store-by%20PhillDanze%20via%20iStock.jpg)
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/The%20Shopify%20logo%20on%20a%20smartphone%20screen%20by%20IB%20Photography%20%20via%20Shutterstock.jpg)
/Starbucks%20Corp_%20logo%20by-%20eyewave%20via%20iStock.jpg)